No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Feb 11, 2019

The Week in Review in Prescription Drug Pricing

Two important people wrote Medium posts this week. You maybe missed this one.

Read Article
News Feb 3, 2019

The Week in Review in Prescription Drug Pricing

Ready your chicken wings, chili bowls, and Tony Romo prediction bets.

Read Article
News Jan 28, 2019

The Week in Review in Prescription Drug Pricing

Pfizer spun its January price hikes as impacting an itsy bitsy portion of its drugs. Too bad the 41 drugs it hiked represent half the pharma giant’s revenue. — (Axios)

Read Article
News Jan 22, 2019

The Week in Review in Prescription Drug Pricing

The hills are alive with the sound of drug pricing reform.

Read Article
News Jan 10, 2019

Patient Advocates Launch $1 Million Campaign To Lower Medicare Part B Drug Prices

Patients For Affordable Drugs Now launched a nearly $1 million campaign in support of the Department of Health and Human Services’ proposal to lower drug prices in Medicare Part B. Under the…

Read Article
News Jan 4, 2019

The Year in Review in Prescription Drug Pricing

It’s a new year and drug pricing reform is here to stay. Here are our top 5 takeaways from 2018:

Read Article
News Dec 18, 2018

Reviews From Experts, Lawmakers, and Patients: The International Pricing Index Will Lower Drug Prices

As Big Pharma spends millions to kill proposed reforms in Medicare Part B, it’s important to keep in mind why: The proposal will lower drug prices and reduce patient out-of-pocket costs.

Read Article
News Dec 17, 2018

The Week in Review in Prescription Drug Pricing

‘Tis the season — for drug corporations to spend tax windfalls buying back billions in stock while refusing to lower drug prices.

Read Article
News Dec 12, 2018

Big Pharma opens its wallet and old playbook to block drug pricing reform

Big Pharma is opening its wallet and pulling out the same old scare tactics to block a proposal that would lower drug prices in Medicare Part B. Under a draft proposal from the Department of Health…

Read Article
News Dec 11, 2018

The Week in Review in Prescription Drug Pricing

Drug companies are asking Congress to reduce their contributions to the Medicare Part D program.

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.